Hidetsugu Ueyama

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

Koji Abe, Masashi Aoki, Shoji Tsuji et al. · The Lancet Neurology · 2017 · 900 citations

Neurodegenerative Diseases, Amyotrophic Lateral Sclerosis, Neurological Disorder +6

Clinical Heterogeneity in Dysferlinopathy.

Hidetsugu Ueyama, Toshihide Kumamoto, Hideo Horinouchi et al. · Internal Medicine · 2002 · 75 citations · Full text

Proteasome expression in the skeletal muscles of patients with muscular dystrophy

T Kumamoto, Shin Fujimoto, Tomoko Ito et al. · Acta Neuropathologica · 2000 · 69 citations

Muscle Function, Kinesiology, Muscle Injury +10

Long-term effects of edaravone on survival of patients with amyotrophic lateral sclerosis

Masamitsu Okada, Satoshi Yamashita, Hidetsugu Ueyama et al. · eNeurologicalSci · 2018 · 66 citations · Full text

Calpain and Cathepsins in the Skeletal Muscle of Inflammatory Myopathies

Toshihide Kumamoto, Hidetsugu Ueyama, Rie Sugihara et al. · European Neurology · 1997 · 47 citations

Mechanobiology, Inflammation, Muscle Function +15